{"a":[{"_":"Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety","$":{"href":"/biotech/definium-hits-another-ph-3-homerun-psychedelic-sea-change-anxiety","hreflang":"en"}}]}
Phase 3positiveLSDPositive
AI Analysis
Summary
Definium Therapeutics' LSD-based therapy achieved positive Phase 3 results in generalized anxiety disorder, marking the second consecutive Phase 3 win for the program following a previous depression trial success.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
Phase 3 trial met primary endpoints in generalized anxiety disorder; second positive Phase 3 result after depression study
Importance:8/10
Sentiment:
0.85
psychedelicLSDanxietyphase 3 successdepression
Read the original article
Published by FierceBiotech on August 11, 2026 5:27 PM